Alaunos Therapeutics, Inc. - Common stock (TCRT)
CUSIP: 98973P309
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 2,198,384
- Total 13F shares
- 70,942
- Share change
- +518
- Total reported value
- $344,079
- Price per share
- $4.85
- Number of holders
- 25
- Value change
- +$2,573
- Number of buys
- 6
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98973P309:
Top shareholders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert W. Postma |
13D/G
|
Postma Robert W |
9%
|
199,796
|
$615,372 | $0 | 24 Jun 2025 | |
| Kevin S. Boyle Sr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
798,236
|
$111,993 | — | 01 Sep 2023 | |
| Raffaele Baffa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
280,645
|
$39,374 | — | 17 May 2021 | |
| BlackRock, Inc. |
13F
|
Company |
0.97%
|
21,353
|
$31,389 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.95%
|
20,972
|
$30,409 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
15,610
|
$22,640 | — | 31 Mar 2025 | |
| Heidi Hagen |
3/4/5
|
Director |
—
class O/S missing
|
145,889
|
$20,468 | — | 02 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
7,869
|
$11,567 | — | 31 Mar 2025 | |
| Christopher Bowden |
3/4/5
|
Director |
—
mixed-class rows
|
144,167
mixed-class rows
|
$6,197 | — | 22 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.08%
|
1,676
|
$2,464 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
897
|
$1,319 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
720
|
$1,051 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
300
|
$753 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
300
|
$435 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
216
|
$318 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
171
|
$251 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
98
|
$144 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
89
|
$131 | — | 31 Mar 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
86
|
$127 | — | 31 Mar 2025 | |
| Na Bokf |
13F
|
Individual |
0%
|
66
|
$97 | — | 31 Mar 2025 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
54
|
$80 | — | 31 Mar 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
24
|
$35 | — | 31 Mar 2025 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
23
|
$34 | — | 31 Mar 2025 | |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. |
13F
|
Company |
0%
|
21
|
$30 | — | 31 Mar 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
19
|
$28 | — | 31 Mar 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
10
|
$15 | — | 31 Mar 2025 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
10
|
$15 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
6
|
$9 | — | 31 Mar 2025 | |
| INVESTMENT MANAGEMENT CORP /VA/ /ADV |
13F
|
Company |
0%
|
6
|
$9 | — | 31 Mar 2025 | |
| PSI Advisors, LLC |
13F
|
Company |
0%
|
6
|
$9 | — | 31 Mar 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
2
|
$3 | — | 31 Mar 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Mar 2025 | |
| Eleanor de Groot |
3/4/5
|
EVP, Operations |
—
class O/S missing
|
350,000
|
— | — | 30 Mar 2022 | |
| Abhishek K. Srivastava |
3/4/5
|
Vice President, Technical Operations |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Drew Deniger |
3/4/5
|
Vice President, Research and Development |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Michael Wong |
3/4/5
|
Vice President, Finance |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| James Huang |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Mary Thistle |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Robert Hofmeister |
3/4/5
|
Director |
—
class O/S missing
|
12,800
|
— | — | 06 Jun 2024 | |
| Dale Curtis Hogue Jr. |
3/4/5
|
Chief Executive Officer, Interim, Director |
—
class O/S missing
|
3,000
|
— | — | 29 Mar 2025 | |
| Melinda Lackey |
3/4/5
|
Legal & Administration |
—
class O/S missing
|
1,000
|
— | — | 29 Mar 2025 |
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q2 2025
As of 30 Jun 2025,
Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,942 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, MORGAN STANLEY, Steward Partners Investment Advisory, LLC, Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., CIBC Private Wealth Group LLC, and GROUP ONE TRADING LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
25
Q2 2025 holders
25
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.